An Indian business publication is reporting that U.S. investment bank Goldman Sachs is making a $20 million equity investment in an Indian medical device company.

BPL Medical Technologies makes electrocardiographs, defibrillators, patient monitors, oxygenators and ultrasound scanners among other medical equipment and is part of the BPL Group, which makes consumer appliances and home entertainment products like TVs.

The article notes that Goldman Sachs has already invested more than $2 billion in Indian companies since 2006 and they include healthcare industry investments in Nova Medical Centers and Max India. Nova Medical Centers owns and operates a group of surgical and In-vitro fertility centers in the Asian nation. Max India has a healthcare subsidiary which operates hospitals throughout the country. 

The report notes what Ankur Sahu, co-head of private equity in Asia making the following statement:

According to other press reports, Goldman's equity inivestment marks the second instance of a global private equity firm betting on the local Indian medical device industry. In April, TPG reportedly invested $23 million in Sutures India, which makes surgical consumables. 

With foreign capital flowing to local companies, competition from local device makers is likely to heat up as U.S. device makers are also making a beeline to tap into fast-growing device market. Aside from foreign capital, device makers in places like China also benefit from government prioritizing local innovation.

-- By Arundhati Parmar, Senior Editor, MD+DI

Related Content

Be Ready to Compete with Local Firms in Chinese Device Market

Going it Alone is a Poor Strategy in Trying to Break into Emerging Markets